SecBot SecBot
8-K ·Filed Apr 23, 2026

EW

Edwards Lifesciences Corp
BULLISH
Impact 8/10
Horizonweeks Processed6mo ago SEC0001099800-26-000021
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

Monitor next quarter for sustained TMTT growth and margin expansion, as raised guidance and strong TAVR/TMTT momentum signal continued outperformance.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$84.10
T+0 close · Apr 23, 2026 · via day close
Latest settled
+1.07%
T+60 · $85.00
Vs SPY
−2.87%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 24 $84.10entry
  2. T+1 · 7mo ago −1.07%α −1.23% · $83.20
  3. T+5 · 7mo ago −0.71%α −1.62% · $83.50
  4. T+20 · 6mo ago −1.07%α −5.09% · $83.20
  5. T+60 · 4mo ago +1.07%α −2.87% · $85.00
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Edwards Lifesciences reported strong Q1 2026 results with sales up 16.7% to $1.65B and adjusted EPS of $0.78, beating consensus by $0.05. The company raised full-year 2026 guidance for sales growth to 9-11% (from 8-10%) and adjusted EPS to $2.95-$3.05 (from $2.90-$3.05), citing strong TAVR and TMTT momentum and clinical catalysts.

Key Financial Metrics

EPS
$0.78
est $0.73 · +6.8%
Revenue
$1.6B
est $1.6B · +3.0% · +16.7% YoY
Rating
beat
Guidance
$6.5B-$6.9B
raised
Gross Margin
78%

Key Facts

  • Q1 sales grew 16.7% YoY to $1.65B, constant currency growth of 12.7%
  • Q1 adjusted EPS was $0.78, beating consensus of $0.73
  • Raised full-year 2026 constant currency sales growth guidance to 9-11% (from 8-10%)
  • Raised full-year 2026 adjusted EPS guidance midpoint to $2.95-$3.05 (from $2.90-$3.05)
  • Completed $500M accelerated share repurchase

Financial Impact

$0.05 EPS beat and raised full-year guidance

revenueepsguidance

Risk Factors

  • Increased guidance raises bar for future quarters
  • TMTT growth may face competitive pressures

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001099800-26-000021
Document: ew-20260423.htm0001099800-26-000021
Document: 0001099800-26-000021-index-headers.html0001099800-26-000021
Document: 0001099800-26-000021-index.html0001099800-26-000021
Document: 0001099800-26-000021.txt0001099800-26-000021
8-K Data (Synthetic)0001099800-26-000021

Track record

27 reports on EW

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
  2. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
  3. Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
  4. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
  5. Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
  7. Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
  8. Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
  9. Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
  10. Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens in 8h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026